TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Repolar Pharmaceuticals Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
956
|
853
|
928 |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
88
|
1
|
0 |
| Total assets |
607
|
525
|
510 |
| Current assets |
128
|
84
|
470 |
| Current liabilities |
102
|
89
|
75 |
| Equity capital |
506
|
436
|
435 |
| - share capital |
53
|
53
|
53 |
| Employees (average) |
6
|
4
|
5 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
83.4%
|
83.0%
|
85.3% |
| Turnover per employee |
159
|
213
|
186 |
| Profit as a percentage of turnover |
9.2%
|
0.1%
|
0% |
| Return on assets (ROA) |
0.4%
|
0% | |
| Current ratio |
125.5%
|
94.4%
|
626.7% |
| Return on equity (ROE) |
17.4%
|
0.2%
|
0% |
| Change turnover |
103
|
-75 | |
| Change turnover % |
12%
|
-8% | |
| Chg. No. of employees |
2
|
-1 | |
| Chg. No. of employees % |
50%
|
-20% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.